Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study
暂无分享,去创建一个
A. Pesenti | R. Latini | M. Stridsberg | G. Christensen | T. Omland | H. Røsjø | S. Masson | L. Gattinoni | P. Caironi | G. Moise | M. Magnoli | Maria Cristina Urbano | Michela Magnoli
[1] Alan E. Jones,et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.
[2] E. Ruokonen,et al. Prognostic Value of Secretoneurin in Critically Ill Patients With Infections , 2016, Critical care medicine.
[3] V. Pettilä,et al. Prognostic Value of Secretoneurin in Patients with Acute Respiratory Failure: Data from the FINNALI Study. , 2016, Clinical chemistry.
[4] R. Latini,et al. Cardiac dysfunction and circulating cardiac markers during sepsis. , 2016, Minerva anestesiologica.
[5] Takashi Ito,et al. Sepsis-induced myocardial dysfunction: pathophysiology and management , 2016, Journal of Intensive Care.
[6] G. Tognoni,et al. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock* , 2015, Critical care medicine.
[7] C. Carlson,et al. Secretoneurin is a novel prognostic cardiovascular biomarker associated with cardiomyocyte calcium handling. , 2015, Journal of the American College of Cardiology.
[8] D. Otten. Albumin Replacement in Patients with Severe Sepsis or Septic Shock , 2014 .
[9] E. Fiaccadori,et al. Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment. , 2014, Journal of critical care.
[10] M. Antonelli,et al. Albumin replacement in patients with severe sepsis or septic shock. , 2014, The New England journal of medicine.
[11] T. van der Poll,et al. Severe sepsis and septic shock. , 2013, The New England journal of medicine.
[12] R. Hotchkiss,et al. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. , 2013, The Lancet. Infectious diseases.
[13] R. Kishore,et al. The Angiogenic Factor Secretoneurin Induces Coronary Angiogenesis in a Model of Myocardial Infarction by Stimulation of Vascular Endothelial Growth Factor Signaling in Endothelial Cells , 2012, Circulation.
[14] Ralph B D'Agostino,et al. Misuse of DeLong test to compare AUCs for nested models , 2012, Statistics in medicine.
[15] I. Sjaastad,et al. Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties , 2012, PloS one.
[16] Y. Loh,et al. The extended granin family: structure, function, and biomedical implications. , 2011, Endocrine reviews.
[17] J. Vincent,et al. Is worsening multiple organ failure the cause of death in patients with severe sepsis?* , 2011, Critical care medicine.
[18] Ewout W Steyerberg,et al. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.
[19] E. Ruokonen,et al. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study , 2007, Intensive Care Medicine.
[20] J. Vincent,et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.
[21] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.